ABOUT US
Affacare Medical (Beijing) Co., Ltd.
Dedicated to building the company into a surgical instrument platform company.
Beijing Affacare Medical Co., Ltd., founded in 2012, was the first high-tech enterprise in China to achieve the domestic production of surgical ultrasonic scalpels. The company pioneered the "One Patient, One Scalpel" usage concept, driving the industry's shift toward single-use ultrasonic scalpels.
Since its establishment, Affacare has focused on the R&D, manufacturing, and sales of minimally invasive surgical products, including ultrasonic scalpels and ultrasonic pneumatic lithotripsy systems. The company is dedicated to reducing healthcare costs through technological innovation, making high-quality surgical instruments more accessible.
With over 70 patents, Affacare’s self-developed ultrasonic surgical system meets the advanced standards of international counterparts and has been selected for the Excellent Domestic Medical Device Product Catalog. The company holds certifications including GMP, ISO 13485, and MDSAP, along with regulatory approvals from NMPA, CE, and others. Its products serve more than 1,800 medical institutions across China and have been used in over one million surgical procedures.
Looking ahead, Affacare remains committed to its mission: “Dedicated to Every Surgery.” The company plans to expand its product portfolio to include energy platforms, endoscopic consumables, and tumor ablation solutions, while continuing to deepen its expertise in minimally invasive surgery and accelerate global expansion—striving to become a trusted surgical partner for surgeons worldwide.
13 years of industry experience
The company currently has more than 300 employees.
Obtained over 70 national patents.
Serving over 2,200 medical institutions.
Over 2 million surgical procedures have been performed in clinical practice.
Over 20 countries for global business expansion